Public–private interaction in pharmaceutical research
- 12 November 1996
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (23) , 12725-12730
- https://doi.org/10.1073/pnas.93.23.12725
Abstract
We empirically examine interaction between the public and private sectors in pharmaceutical research using qualitative data on the drug discovery process and quantitative data on the incidence of coauthorship between public and private institutions. We find evidence of significant reciprocal interaction, and reject a simple "linear" dichotomous model in which the public sector performs basic research and the private sector exploits it. Linkages to the public sector differ across firms, reflecting variation in internal incentives and policy choices, and the nature of these linkages correlates with their research performance.Keywords
This publication has 17 references indexed in Scilit:
- Competitive advantages from in-house scientific research: The US pharmaceutical industry in the 1980sPublished by Elsevier ,2002
- THE VERTICAL CHAIN OF RESEARCH AND DEVELOPMENT IN THE PHARMACEUTICAL INDUSTRYEconomic Inquiry, 1995
- SELECTING A SELLING INSTITUTION: AUCTIONS VERSUS SEQUENTIAL SEARCHEconomic Inquiry, 1995
- How to find a treatment for Alzheimer's diseaseNeurobiology of Aging, 1994
- Measuring Competence? Exploring Firm Effects in Pharmaceutical ResearchStrategic Management Journal, 1994
- Racing To Invest? The Dynamics of Competition in Ethical Drug DiscoveryJournal of Economics & Management Strategy, 1994
- Toward a new economics of scienceResearch Policy, 1994
- Innovation and Learning: The Two Faces of R & DThe Economic Journal, 1989
- Issues in Assessing the Contribution of Research and Development to Productivity GrowthThe Bell Journal of Economics, 1979
- The productivity of research effort in the US pharmaceutical industry: a statistical approachResearch Policy, 1975